Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2023

03.06.2023 | Original Laboratory Investigation

Palliative care utilization and racial and ethnic disparities among women with de novo metastatic breast cancer in the United States

verfasst von: Fantine Giap, Sung Jun Ma, Oluwadamilola T. Oladeru, Young-Rock Hong, Brian Yu, Raymond B. Mailhot Vega, Eric D. Brooks, Anurag K. Singh, Paul G. Okunieff, Nancy P. Mendenhall, Julie A. Bradley

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The potential disparities in palliative care delivery for underrepresented minorities with breast cancer are not well known. We sought to determine whether race and ethnicity impact the receipt of palliative care for patients with metastatic breast cancer (MBC).

Methods

We retrospectively reviewed the National Cancer Database for female patients diagnosed with stage IV breast cancer between 2010 and 2017 who received palliative care following diagnosis of MBC to assess the proportion of patients who received palliative care, including non–curative-intent local–regional or systemic therapy. Multivariable logistic regression analysis was performed to identify variables associated with receiving palliative care.

Results

60,685 patients were diagnosed with de novo MBC. Of these, only 21.4% (n = 12,963) received a palliative care service. Overall, there was a positive trend in palliative care receipt from 18.2% in 2010 to 23.0% in 2017 (P < 0.001), which persisted when stratified by race and ethnicity. Relative to non-Hispanic White women, Asian/Pacific Islander women (aOR 0.80, 95% CI 0.71–0.90, P < 0.001), Hispanic women (adjusted odds ratio [aOR] 0.69, 95% CI 0.63–0.76, P < 0.001), and non-Hispanic Black women (aOR 0.94, 95% CI 0.88–0.99, P = 0.03) were less likely to receive palliative care.

Conclusions

Fewer than 25% of women with MBC received palliative care between 2010 and 2017. While palliative care has significantly increased for all racial/ethnic groups, Hispanic White, Black, and Asian/Pacific Islander women with MBC still receive significantly less palliative care than non-Hispanic White women. Further research is needed to identify the socioeconomic and cultural barriers to palliative care utilization.
Literatur
1.
Zurück zum Zitat Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics, 2021. CA: Cancer J Clin 71(1):7–33PubMed Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics, 2021. CA: Cancer J Clin 71(1):7–33PubMed
2.
Zurück zum Zitat Geels P, Eisenhauer E, Bezjak A, Zee B, Day A (2000) Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. J Clin Oncol 18(12):2395–2405CrossRefPubMed Geels P, Eisenhauer E, Bezjak A, Zee B, Day A (2000) Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. J Clin Oncol 18(12):2395–2405CrossRefPubMed
3.
Zurück zum Zitat Kavalieratos D, Corbelli J, Zhang D, Dionne-Odom JN, Ernecoff NC, Hanmer J et al (2016) Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA 316(20):2104–2114CrossRefPubMedPubMedCentral Kavalieratos D, Corbelli J, Zhang D, Dionne-Odom JN, Ernecoff NC, Hanmer J et al (2016) Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA 316(20):2104–2114CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J et al (2009) Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA 302(7):741–749CrossRefPubMedPubMedCentral Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J et al (2009) Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA 302(7):741–749CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z et al (2015) Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol 33(13):1438–1445CrossRefPubMedPubMedCentral Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z et al (2015) Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol 33(13):1438–1445CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A et al (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383(9930):1721–1730CrossRefPubMed Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A et al (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383(9930):1721–1730CrossRefPubMed
7.
Zurück zum Zitat Vanbutsele G, Pardon K, Van Belle S, Surmont V, De Laat M, Colman R et al (2018) Effect of early and systematic integration of palliative care in patients with advanced cancer: a randomised controlled trial. Lancet Oncol 19(3):394–404CrossRefPubMed Vanbutsele G, Pardon K, Van Belle S, Surmont V, De Laat M, Colman R et al (2018) Effect of early and systematic integration of palliative care in patients with advanced cancer: a randomised controlled trial. Lancet Oncol 19(3):394–404CrossRefPubMed
8.
Zurück zum Zitat Grudzen CR, Richardson LD, Johnson PN, Hu M, Wang B, Ortiz JM et al (2016) Emergency department-initiated palliative care in advanced cancer: a randomized clinical trial. JAMA Oncol 2(5):591–598CrossRefPubMedPubMedCentral Grudzen CR, Richardson LD, Johnson PN, Hu M, Wang B, Ortiz JM et al (2016) Emergency department-initiated palliative care in advanced cancer: a randomized clinical trial. JAMA Oncol 2(5):591–598CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM et al (2017) Integration of palliative care into standard oncology care: American society of clinical oncology clinical practice guideline update. J Clin Oncol 35(1):96–112CrossRefPubMed Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM et al (2017) Integration of palliative care into standard oncology care: American society of clinical oncology clinical practice guideline update. J Clin Oncol 35(1):96–112CrossRefPubMed
10.
Zurück zum Zitat Ren JX, Gong Y, Ling H, Hu X, Shao ZM (2019) Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics. Breast Cancer Res Treat 173(1):225–237CrossRefPubMed Ren JX, Gong Y, Ling H, Hu X, Shao ZM (2019) Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics. Breast Cancer Res Treat 173(1):225–237CrossRefPubMed
11.
Zurück zum Zitat DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A (2017) Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin 67(6):439–448CrossRefPubMed DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A (2017) Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin 67(6):439–448CrossRefPubMed
12.
Zurück zum Zitat Nickolich MS, El-Jawahri A, Temel JS, LeBlanc TW (2016) Discussing the evidence for upstream palliative care in improving outcomes in advanced cancer. Am Soc Clin Oncol Educ Book 35:e534–e538CrossRefPubMed Nickolich MS, El-Jawahri A, Temel JS, LeBlanc TW (2016) Discussing the evidence for upstream palliative care in improving outcomes in advanced cancer. Am Soc Clin Oncol Educ Book 35:e534–e538CrossRefPubMed
13.
Zurück zum Zitat Deeb S, Chino FL, Diamond LC, Tao A, Aragones A, Shahrokni A et al (2021) Disparities in care management during terminal hospitalization among adults with metastatic cancer from 2010 to 2017. JAMA Netw Open 4(9):e2125328CrossRefPubMedPubMedCentral Deeb S, Chino FL, Diamond LC, Tao A, Aragones A, Shahrokni A et al (2021) Disparities in care management during terminal hospitalization among adults with metastatic cancer from 2010 to 2017. JAMA Netw Open 4(9):e2125328CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Sheldon LK (2014) Implementing the new commission on cancer standard on palliative care services. Clin J Oncol Nurs 18(Suppl):37–38CrossRefPubMed Sheldon LK (2014) Implementing the new commission on cancer standard on palliative care services. Clin J Oncol Nurs 18(Suppl):37–38CrossRefPubMed
17.
Zurück zum Zitat Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2020) SEER cancer statistics review, 1975–2017, National Cancer Institute. Bethesda, Apr 2020. https://seer.cancer.gov/csr/1975_2017/, based on November 2019 SEER data submission, posted to the SEER web site. Accessed on 13 Apr 2023 Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2020) SEER cancer statistics review, 1975–2017, National Cancer Institute. Bethesda, Apr 2020. https://​seer.​cancer.​gov/​csr/​1975_​2017/​, based on November 2019 SEER data submission, posted to the SEER web site. Accessed on 13 Apr 2023
18.
Zurück zum Zitat Greer JA, Moy B, El-Jawahri A, Jackson VA, Kamdar M, Jacobsen J et al (2022) Randomized trial of a palliative care intervention to improve end-of-life care discussions in patients with metastatic breast cancer. J Natl Compr Canc Netw 20(2):136–143CrossRefPubMedPubMedCentral Greer JA, Moy B, El-Jawahri A, Jackson VA, Kamdar M, Jacobsen J et al (2022) Randomized trial of a palliative care intervention to improve end-of-life care discussions in patients with metastatic breast cancer. J Natl Compr Canc Netw 20(2):136–143CrossRefPubMedPubMedCentral
Metadaten
Titel
Palliative care utilization and racial and ethnic disparities among women with de novo metastatic breast cancer in the United States
verfasst von
Fantine Giap
Sung Jun Ma
Oluwadamilola T. Oladeru
Young-Rock Hong
Brian Yu
Raymond B. Mailhot Vega
Eric D. Brooks
Anurag K. Singh
Paul G. Okunieff
Nancy P. Mendenhall
Julie A. Bradley
Publikationsdatum
03.06.2023
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2023
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-023-06963-7

Weitere Artikel der Ausgabe 3/2023

Breast Cancer Research and Treatment 3/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.